Galapagos to present at upcoming investor conferences

Mechelen, Belgium; 24 August 2022, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that management will participate in the following upcoming investor conferences:  Citi’s 17th Annual Biopharma Conference. September 8, 2022 in BostonMorgan Stanley 20th Global Healthcare Conference. September 12-14, 2022 in New YorkBank of America Merrill Lynch Global Healthcare Conference. September 15, 2022 in LondonKBC Securities Virtual Life Sciences Conference. September 16, 2022JP Morgan CEO Call Series. September 28, 2022Credit Suisse 31st Annual Healthcare Conference. November 8-10, 2022 in Rancho Palos Verdes, CABryan Garnier Virtual Conference on Cell Therapy Innovation. November 14, 2022Jefferies 2022 Global Healthcare Conference. November 16-17, 2022 in LondonKepler Cheuvreux Virtual Life Science Days. November 21, 2022Deutsche Bank 2022 Call Series. November 30, 2022 Additional information regarding these events will be available on the investor section of the Galapagos website at glpg.com/events. About GalapagosGalapagos is a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to Phase 3 programs in inflammation, oncology, fibrosis, and other indications. Our first medicine for rheumatoid arthritis and ulcerative colitis is approved and available in the European Union (including Norway), Great Britain and Japan. For additional information, please visit www.glpg.com or follow us on LinkedIn or Twitter. ContactInvestors:Sofie Van GijselHead of Investor Relations+1 781 296 1143 Sandra CauwenberghsDirector Investor Relations+32 495 58 46 [email protected] Media:Marieke VermeerschHead of Corporate Communication+32 479 490 [email protected] Forward-looking statements This release may contain forward-looking statements. Such forward-looking statements are not guarantees of future results. These forward-looking statements speak only as of the date of publication of this document. Galapagos expressly disclaims any obligation to update any forward-looking statements in this document, unless specifically required by law or regulation.  

Attachment

Galapagos to present at upcoming investor conferences